CA125 is also a proven or potential biomarker in endometriosis (41), urothelial carcinoma of the bladder (42), lung cancer (43), gastric cancer (44), and colorectal cancer (45, 46). The gene discussed is MUC16; the disease is bladder transitional cell carcinoma.